120 related articles for article (PubMed ID: 17617576)
1. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
Chewning JH; Gudme CN; Hsu KC; Selvakumar A; Dupont B
J Immunol; 2007 Jul; 179(2):854-68. PubMed ID: 17617576
[TBL] [Abstract][Full Text] [Related]
2. Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.
Torres AR; Westover JB; Gibbons C; Johnson RC; Ward DC
Brain Behav Immun; 2012 Oct; 26(7):1122-7. PubMed ID: 22884899
[TBL] [Abstract][Full Text] [Related]
3. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
[TBL] [Abstract][Full Text] [Related]
4. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
Naumova E; Mihaylova A; Ivanova M; Mihailova S
Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
[TBL] [Abstract][Full Text] [Related]
5. Peptide-specific engagement of the activating NK cell receptor KIR2DS1.
Chapel A; Garcia-Beltran WF; Hölzemer A; Ziegler M; Lunemann S; Martrus G; Altfeld M
Sci Rep; 2017 May; 7(1):2414. PubMed ID: 28546555
[TBL] [Abstract][Full Text] [Related]
6. KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity.
Leijonhufvud C; Sanz-Ortega L; Schlums H; Gaballa A; Andersson A; Eriksson C; Segerberg F; Uhlin M; Bryceson YT; Carlsten M
J Immunol; 2024 Mar; 212(5):868-880. PubMed ID: 38240527
[TBL] [Abstract][Full Text] [Related]
7. CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.
Du J; Lopez-Verges S; Pitcher BN; Johnson J; Jung SH; Zhou L; Hsu K; Czuczman MS; Cheson B; Kaplan L; Lanier LL; Venstrom JM
Cancer Immunol Res; 2014 Sep; 2(9):878-89. PubMed ID: 24958280
[TBL] [Abstract][Full Text] [Related]
8. Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans.
Baek IC; Choi EJ; Kim HJ; Choi H; Shin HS; Lim DG; Kim TG
J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202265
[TBL] [Abstract][Full Text] [Related]
9. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
[TBL] [Abstract][Full Text] [Related]
10. Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection.
Legaz I; Bolarín JM; Campillo JA; Moya-Quiles MR; Miras M; Muro M; Minguela A; Álvarez-López MR
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293011
[TBL] [Abstract][Full Text] [Related]
11. KIR-HLA gene diversities and susceptibility to lung cancer.
Hematian Larki M; Ashouri E; Barani S; Ghayumi SMA; Ghaderi A; Rajalingam R
Sci Rep; 2022 Oct; 12(1):17237. PubMed ID: 36241658
[TBL] [Abstract][Full Text] [Related]
12. Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.
Hanson AL; Sahhar J; Ngian GS; Roddy J; Walker J; Stevens W; Nikpour M; Assassi S; Proudman S; Mayes MD; Kenna TJ; Brown MA
Front Genet; 2022; 13():913196. PubMed ID: 35754823
[TBL] [Abstract][Full Text] [Related]
13. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
14. Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.
Falco M; Meazza R; Alicata C; Canevali P; Muntasell A; Bottino C; Moretta L; Pende D; Lopez-Botet M
HLA; 2022 Aug; 100(2):107-118. PubMed ID: 35411634
[TBL] [Abstract][Full Text] [Related]
15. Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19.
Maruthamuthu S; Rajalingam K; Kaur N; Morvan MG; Soto J; Lee N; Kong D; Hu Z; Reyes K; Ng D; Butte AJ; Chiu C; Rajalingam R
Front Genet; 2022; 13():845474. PubMed ID: 35273641
[No Abstract] [Full Text] [Related]
16. Interferon-β acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation.
Fueyo-González F; McGinty M; Ningoo M; Anderson L; Cantarelli C; Andrea Angeletti ; Demir M; Llaudó I; Purroy C; Marjanovic N; Heja D; Sealfon SC; Heeger PS; Cravedi P; Fribourg M
Immunity; 2022 Mar; 55(3):459-474.e7. PubMed ID: 35148827
[TBL] [Abstract][Full Text] [Related]
17. Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.
Makanga DR; Jullien M; David G; Legrand N; Willem C; Dubreuil L; Walencik A; Touzeau C; Gastinne T; Tessoulin B; Le Gouill S; Mahé B; Gagne K; Chevallier P; Clemenceau B; Retière C
Oncoimmunology; 2021 Jun; 10(1):1936392. PubMed ID: 34178429
[TBL] [Abstract][Full Text] [Related]
18. Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia.
Martínez-Sánchez MV; Fuster JL; Campillo JA; Galera AM; Bermúdez-Cortés M; Llinares ME; Ramos-Elbal E; Pascual-Gázquez JF; Fita AM; Martínez-Banaclocha H; Galián JA; Gimeno L; Muro M; Minguela A
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064810
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells.
Burster T; Gärtner F; Bulach C; Zhanapiya A; Gihring A; Knippschild U
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
